Endometrial Cancer Trial, Recruiting (NCT06420427)

Endometrial Cancer Trial, Recruiting NCT06420427 Sponsor: The Third Affiliated Hospital of Guangzhou Medical University Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06420427 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been newly diagnosed with HPV-positive cervical cancer at any stage (I through IV) and have not yet had surgery, radiation therapy, or chemotherapy.
People who are older than 18 years of age.
People whose cervical cancer has been assessed as suitable for surgery and/or combined chemotherapy and radiation treatment.
People who have an estimated life expectancy of more than three months.
People who understand the study plan and are willing to take part by signing a consent form.
People who are able to provide tissue or blood samples and relevant medical information at each required point during the study.

Who may not be able to join:

People who are currently taking part in another clinical trial.
People who are pregnant or breastfeeding.
People who have been diagnosed with a severe mental illness.
People who choose to withdraw from the study.
People who would be unable to complete the full study plan.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Xiujie Sheng, Prof, The Third Affiliated Hospital of Guangzhou Medical University

Phone: 86-20-81292726

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06420427

Sponsor: The Third Affiliated Hospital of Guangzhou Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 86-20-81292726

More information: https://clinicaltrials.gov/study/NCT06420427

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been newly diagnosed with HPV-positive cervical cancer at any stage (I through IV) and have not yet had surgery, radiation therapy, or chemotherapy.
People who are older than 18 years of age.
People whose cervical cancer has been assessed as suitable for surgery and/or combined chemotherapy and radiation treatment.
People who have an estimated life expectancy of more than three months.
People who understand the study plan and are willing to take part by signing a consent form.
People who are able to provide tissue or blood samples and relevant medical information at each required point during the study.

Who may not be able to join:

People who are currently taking part in another clinical trial.
People who are pregnant or breastfeeding.
People who have been diagnosed with a severe mental illness.
People who choose to withdraw from the study.
People who would be unable to complete the full study plan.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

The Third Affiliated Hospital of Guangzhou Medical University

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

sensitivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov